Related Experiment Video
Updated: Aug 10, 2026
08:55
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Current treatment for ovarian cancer
1Division of Gynecologic Oncology, University of Vermont, MCHV Campus, 111 Colchester Avenue, Shepardson 330, Burlington, VT 05401, USA. gamal.eltabbakh@vtmednet.org
Expert Opinion on Pharmacotherapy
|May 5, 2001
Summary
Epithelial ovarian cancer (EOC) is a lethal gynecologic malignancy. While initial chemotherapy shows high response rates, most patients experience recurrence, necessitating research into novel treatments and chemoresistance modulators.
Area of Science:
- Gynecologic Oncology
- Medical Oncology
Background:
- Ovarian cancer is the most lethal gynecologic malignancy, with epithelial ovarian cancer (EOC) comprising 90% of cases.
- Approximately 70% of EOC patients are diagnosed at an advanced stage, complicating treatment and prognosis.
- Standard treatment involves cytoreductive surgery and adjuvant chemotherapy, typically paclitaxel and platinum-based agents.
Purpose of the Study:
- To review current treatment strategies for epithelial ovarian cancer.
- To highlight the challenges of tumor recurrence and platinum resistance.
- To identify future research directions for improving ovarian cancer treatment outcomes.
Main Methods:
- Literature review of current therapeutic approaches for epithelial ovarian cancer.
- Analysis of treatment efficacy, recurrence rates, and resistance mechanisms.
- Identification of emerging therapeutic strategies and research priorities.
Main Results:
- Paclitaxel and platinum chemotherapy achieves an 80% response rate but is often followed by tumor recurrence within 3 years.
- Platinum-resistant EOC has a poor prognosis with limited palliative treatment options.
- Re-treatment options exist for platinum-sensitive recurrent disease.
Conclusions:
- Despite advances, ovarian cancer recurrence and chemoresistance remain significant challenges.
- Future research should focus on optimizing cytoreductive surgery, developing novel chemotherapeutic agents, and exploring chemoresistance modulators.
- New treatment approaches are crucial for improving survival rates in women with ovarian cancer.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...